Sfoglia per AUTORE
DUREZ P
Collezione ASL Città di Torino

  

Items : 1

Baricitinib, methotrexate, or baricitinib plus methotrexate in patients with moderately-toseverely active rheumatoid arthritis who had received limited or no treatment with dmards: Efficacy and safety results from the 52-week phase 3 ra-begin study in Rheumatology (United Kingdom)

2017
ASL Città di Torino

Holzkämper T; Arthanari S; Pum G; Leage SL; Gjertsson I; Stoykov I; Otawa S; Rogai V; Larsson E; Zamani O; Tahir H; Geusens P; Van Den Bosch F; Shaikh S; Roccatello D; Durez P; De La Torre I; Kekow J; Puttini PS; Walker D;